Drug application
NEVIRAPINE (NEVIRAPINE)
Drugs@FDA ANDA 203021 · APOTEX INC
Key facts
| Drug name | NEVIRAPINE |
|---|---|
| Active ingredients | NEVIRAPINE |
| Application type | ANDA |
| Application number | 203021 |
| Company | APOTEX INC |
| Dosage forms | TABLET, ORAL |
| Strength | 200MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 22, 2012 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.